There were 527 press releases posted in the last 24 hours and 171,013 in the last 365 days.

REVA to Hold First Quarter 2018 Financial Results Call

/EIN News/ -- SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) has scheduled a conference call to review its first quarter 2018 financial results and provide a business update.

The call is scheduled for 2:00 p.m. US PDT on Wednesday, May 9, 2018 (which is 7:00 a.m. AEST on Thursday, 10 May 2018) and may be accessed within the United States and Canada by dialing 1-877-312-5413 five minutes prior to the scheduled start time. Callers within Australia may access the call toll-free by dialing 1800 005 989. The conference ID is 1993886 for all locations.

If you reside outside of the United States, Canada, or Australia, or if you prefer to access the call through our website, please visit “Events & Presentations” under the “Investors” section of our website at, and click on the “listen to webcast” link. A live webcast and transcript of the call will also be available on our website.

About REVA Medical
REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company’s lead products are the Fantom and Fantom Encore bioresorbable vascular scaffolds for the treatment of coronary artery disease. REVA is located in San Diego, California, USA and employs over 50 people in the U.S. and Europe.

Fantom and Fantom Encore are trademarks of REVA Medical, Inc.

  United States Australia Australia
  Investor & Media Enquiries: Investor Enquiries: Media Enquiries:
  REVA Medical, Inc. Inteq Limited Buchan Consulting
  Brandi Roberts Kim Jacobs Rebecca Wilson
  Chief Financial Officer +61 438 217 279 +61 3 9866 4722
  +1 858-966-3003 Andrew Cohen  
  Cheryl Liberatore +61 408 333 452  
  Director, Communications    
  +1 858-966-3045    

Primary Logo

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.